Sat.Jun 18, 2022 - Fri.Jun 24, 2022

Mixed results for PTC Duchenne drug put spotlight on EU approval

Bio Pharma Dive

A confirmatory study of PTC Therapeutics’ muscular dystrophy treatment Translarna missed its main goal, although the company highlighted the trial’s overall positive results

Drugs 254

Disruption in healthcare is coming

World of DTC Marketing

Advanced economies typically spend about 10% of GDP on keeping their citizens in good health, a share that is rising as populations age. America’s profit-riddled healthcare-industrial complex consumes 17% of GDP, equivalent to $3.6trn a year. That is unsustainable.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ultra-thin film creates vivid 3D images with large field of view


WASHINGTON — Researchers have developed a new ultra-thin film that can create detailed 3D images viewable under normal illumination without any special reading devices. The images appear to float on top of the film and exhibit smooth parallax, which means they can be clearly viewed from all angles.

Covid-19 vaccines targeting Omicron variants expected to be ready for this autumn

Pharmaceutical Technology

As regulatory agencies gear up for another round of Covid-19 vaccine deliberations centered on emerging variants, Moderna has released data on its booster’s efficacy against Omicron subvariants. In addition to providing protection against the Omicron BA.1

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Novartis hunting for sickle cell cure with Precision deal

Bio Pharma Dive

The pharma will pay $75 million to access Precision’s gene editing technology, adding another program to the lengthening list of drug development efforts targeting the inherited blood condition

Uniqueness if pharma DTC

World of DTC Marketing

Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience. Some will lead to more online research, while others may not.

More Trending

Novavax’s Covid-19 vaccine gets Taiwan FDA EUA for use in adults

Pharmaceutical Technology

Novavax has obtained emergency use authorization (EUA) for its Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), from the Taiwan Food and Drug Administration for use in people of the age 18 years and above.

Radius, maker of bone and cancer drugs, to be bought in take-private deal

Bio Pharma Dive

Two investment firms, Gurnet Point Capital and Patient Square Capital, have agreed to pay as much as $890 million for Radius, which has come under pressure amid share price declines

Drugs 244

Key Tips for Health Insurance Appeals

Triage Cancer

We’re sharing some key tips to help you receive the care you need if your health insurance company denies coverage for your medical care.

New hybrid machine learning forecasts lake ecosystem responses to climate change


Throughout the middle of the 20th century, phosphorus inputs from detergents and fertilizers degraded the water quality of Switzerland’s Lake Geneva, spurring officials to take action to remediate pollution in the 1970s.


An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

EC approves Novartis’ Tabrecta for non-small cell lung cancer

Pharmaceutical Technology

The European Commission (EC) has approved Novartis’ Tabrecta (capmatinib) as a monotherapy to treat advanced non-small cell lung cancer (NSCLC) in adults.

Galapagos, with latest deals, charts an unexpected journey to cell therapy

Bio Pharma Dive

The Belgian drugmaker will spend more than $100 million to acquire two companies, CellPoint and AboundBio, in a move meant to “disrupt” CAR-T treatment


More Americans Are Dying of Drug Overdoses Than Ever Before

NY Times

Why haven’t we solved the addiction crisis?

Drugs 77

Rensselaer researchers make virus-fighting face masks


Rensselaer Polytechnic Institute researchers have developed an accessible way to make N95 face masks not only effective barriers to germs, but on-contact germ killers.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Eisai’s brain health tool NouKNOW used in Tokyo dementia project


Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed at improving the management of dementia.

Trials 109

UniQure buoyed by early data for Huntington's gene therapy

Bio Pharma Dive

After one year, researchers detected important protein changes in patients who received a low dose of the experimental treatment. Further testing and functional data are needed to assess its potential, however

Benefits of PCD Pharma Company

Fossil Remedies

If you see the growth pattern of the Indian economy, then it has been tremendous. The country has done remarkably well and despite the setback after the pandemic, it is roaring high with full speed. All sector of the Indian economy has done good, but the pharma sector is doing exceptionally well.

Flawed AI makes robots racist, sexist


A robot operating with a popular internet-based artificial intelligence system consistently gravitates to men over women, white people over people of color, and jumps to conclusions about peoples’ jobs after a glance at their face.


CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback

Fierce Pharma

CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback. zbecker. Thu, 06/23/2022 - 16:17


Pfizer takes stake in Lyme disease partner ahead of key study

Bio Pharma Dive

Valneva will receive $95 million from Pfizer to support development of a vaccine candidate as the French company’s COVID-19 work sputters

University of Strathclyde develops 3D breast cancer screening tool


Pre-clinical screening technology could increase cancer test numbers by 50 times

Scientists unravel mysterious mechanism behind “whisker crystal” growth


Tokyo, Japan – Scientists from Tokyo Metropolitan University have discovered the mechanism behind the rapid growth of ultra-thin nanowires or “whiskers” in organic compounds.

Amid monkeypox outbreak, Siga Technologies nabs $13M in smallpox drug orders

Fierce Pharma

Amid monkeypox outbreak, Siga Technologies nabs $13M in smallpox drug orders. zbecker. Thu, 06/23/2022 - 10:16

Drugs 99

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

Bio Pharma Dive

The company says a recent coverage decision by Medicare has forced it to end an observational trial of the Alzheimer's drug after enrolling just 29 participants

Trials 241

CVS Health Banks on Trust to Increase Diversity in Clinical Trials


CVS Health has seen about 40% patient diversity in the work it has done so far, Josh Rose, VP and head of decentralized clinical trials, site solutions and strategy told BioSpace

Offshore wind farms expected to reduce clam fishery revenue, study finds


An important East Coast shellfish industry is projected to suffer revenue losses as offshore wind energy develops along the U.S. Northeast and Mid-Atlantic coasts, according to two Rutgers studies. Credit: © The Author(s) 2022.

Lilly’s Verzenios gets NICE blessing for early-stage breast cancer

Pharma Phorum

Thousands more people with breast cancer in England look set to be eligible for routine treatment with Eli Lilly’s Verzenios, after new guidance from NICE backed use of the drug after surgery for early-stage tumours.

BioMarin's hemophilia gene therapy recommended for approval in Europe

Bio Pharma Dive

The decision brings what could be the first approved hemophilia gene therapy, Roctavian, closer to market, after a series of regulatory setbacks that have delayed its arrival

US frets over pharma supply chain security


The pandemic highlighted how fragile the global manufacturing network is, as supply of certain products was limited and regulatory inspections became difficult to carry out.

UTHealth Houston study: Flu vaccination linked to 40% reduced risk of Alzheimer’s disease


People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.

BioMarin's hemophilia gene therapy Roctavian wins conditional EU backing amid FDA delay

Fierce Pharma

BioMarin's hemophilia gene therapy Roctavian wins conditional EU backing amid FDA delay. Fri, 06/24/2022 - 10:43

Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use

Bio Pharma Dive

Breyanzi is now approved in the second-line setting, matching Gilead’s Yescarta, which won a similar clearance from the FDA earlier this year


AZ preps FDA filing for $3.6bn amyloidosis drug eplontersen

Pharma Phorum

Armed with new phase 3 data, AstraZeneca is preparing to file for regulatory approval of eplontersen, an antisense drug for one of the complications of the disease transthyretin amyloidosis (ATTR) it licensed from Ionis in a $3.6 billion deal last year.

Designable spatially coherent wideband radiation and frequency conversion


Components of a typical laser include gain medium, laser pumping energy and resonant optical cavity. The output frequency of most lasers is fixed or within a small range, and it is difficult to generate lasers of some frequencies by common ways.